Developed by a team of experts from organizations including The Massachusetts Institute of Technology, Nike, Apple, IDEO and Massachusetts General Hospital, Quanttus combines breakthroughs in vital signs monitoring with advances in contextual analysis to create wearable technologies that, for the first time, help people proactively understand their bodies and improve their health. Quanttus wearable devices measure the most clinical-grade vital signs while seamlessly integrating into every part of your life from work to play to rest. Instead of simply delivering data, Quanttus delivers the most complete picture of your wellbeing and personalized insights to improve your health and to live well.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
02/24/14 | $19,000,000 | Series A |
Matrix Partners | undisclosed |